← Eichor
Condition: Npdr Non Proliferative Diabetic Retinopathy Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Npdr Non Proliferative Diabetic Retinopathy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
Phase 2 · 26 location(s) · Vantage Biosciences Ltd · NCT06770933High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy
Phase 4 · 1 location(s) · Retina Consultants of Orange County · NCT06662994Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation
Phase 2 · 1 location(s) · Qlaris Bio, Inc. · NCT07354477A Study to Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferative Diabeti
Phase 3 · 1 location(s) · Ocular Therapeutix, Inc. · NCT07235085A Study Intravitreal THN391 in Diabetic Macular Oedema Secondary to Non-Proliferative Diabetic Retinopathy.
Phase 1 · 7 location(s) · Therini Bio Pty Ltd · NCT06701721Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy
NA · 2 location(s) · Xuxiang Zhang, MD · NCT06713720Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein Occlusion
Phase 2 · 1 location(s) · Annexin Pharmaceuticals AB · NCT07259928Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy
Phase 3 · 30 location(s) · Beletalent (Zhuhai) Pharmaceutical Co., Ltd · NCT06817265
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.